Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000372030

Medchemexpress LLC Pritelivir mesylate | 1428333-96-3 | C19H22N4O6S3 | 50 MG
SDP

Catalog No. 5000372030
Encompass_Preferred

Pritelivir mesylate (BAY 57-1293 mesylate) is an inhibitor of the viral helicase-primase complex, demonstrating antiviral activity both in vitro and in animal models of herpes simplex virus (HSV) infection. It is active against HSV-1 and HSV-2 with an IC50 of 0.02 μM, making it the first in a class of antiviral agents to target this complex for HSV replication inhibition.

  • Exhibits antiviral activity against HSV-1 and HSV-2
  • Inhibits the viral helicase-primase complex
  • Significantly increases survival and reduces mortality in animal models of HSV-1 infection
  • Possesses potent and resistance-breaking antiviral efficacy
  • Potential for treating life-threatening HSV type 1 and 2 infections, including herpes simplex encephalitis
  • Protective when used in combination therapies with Acyclovir against HSV-2

Catalog No. 50-003-72030 Supplier Medchemexpress LLC Supplier No. HY15303A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pritelivir mesylate (BAY 57-1293 mesylate) is an inhibitor of the viral helicase-primase complex, demonstrating antiviral activity both in vitro and in animal models of herpes simplex virus (HSV) infection. It is active against HSV-1 and HSV-2 with an IC50 of 0.02 μM, making it the first in a class of antiviral agents to target this complex for HSV replication inhibition.

  • Exhibits antiviral activity against HSV-1 and HSV-2
  • Inhibits the viral helicase-primase complex
  • Significantly increases survival and reduces mortality in animal models of HSV-1 infection
  • Possesses potent and resistance-breaking antiviral efficacy
  • Potential for treating life-threatening HSV type 1 and 2 infections, including herpes simplex encephalitis
  • Protective when used in combination therapies with Acyclovir against HSV-2

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.